Skip to content

Zinc Supplementation in Cirrhotic Patients

Zinc Supplementation as Treatment of Dysgeusias in Cirrhotic Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02475928
Acronym
ZnDCP
Enrollment
70
Registered
2015-06-19
Start date
2015-04-30
Completion date
2019-12-31
Last updated
2019-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysgeusia, Liver Cirrhosis

Brief summary

The purpose of this study is to evaluate the effect of zinc supplementation in the treatment for dysgeusia, progression disease and quality of life in patients with liver cirrhosis.

Detailed description

Taste disorders are symptomatologies in patients with cirrhosis, these have a direct effect in modification of food consumption, increasing weight loss, anorexia and malnutrition, which impacts in decompensation rates and mortality. It has been proposed that zinc deficiency is one of the causes for development of taste disorders. The aim of this study is to describe the presence of taste disorders in patients with cirrhosis and evaluate the effect of zinc supplementation in treatment of taste disorders, and in progression of chronic liver disease.

Interventions

DIETARY_SUPPLEMENTzinc gluconate

Zinc supplementation plus nutritional education

DIETARY_SUPPLEMENTPlacebo

Sponsors

Fundación Clínica Médica Sur
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Cirrhotic patients by any etiology, with any dysgeusia

Exclusion criteria

* Patients with hepatic encephalopathy at the time of dysgeusia evaluation * Patients with any neurological disease * Patients with respiratory diseases ath the time of dysgeusia evaluation * Patients with active alcohol consumption

Design outcomes

Primary

MeasureTime frameDescription
DysgeusiaPresence of any taste disorder at 6 monthsEvaluation of presence of any taste disorder, according to questionnaires and evaluation of perception and recognition thresholds with ascending molar concentrations of basic tastes.

Countries

Mexico

Contacts

Primary ContactNorberto C Chávez-Tapia, PhD
nchavezt@medicasur.org.mx54246850
Backup ContactEva Juárez-Hernández
evajuarezh@hotmail.com54246850

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026